桥本甲状腺炎合并甲状腺乳头状癌的研究进展  

Research progress of Hashimoto thyroiditis combined with papillary thyroid cancer

作　　者：张翰玲 晋建华[1] Zhang Hanling;Jin Jianhua(Department of Nuclear Medicine,the First Hospital of Shanxi Medical University,Taiyuan 030001,China)

机构地区：[1]山西医科大学第一医院核医学科,太原030001

出　　处：《国际放射医学核医学杂志》2020年第11期717-721,共5页International Journal of Radiation Medicine and Nuclear Medicine

摘　　要：桥本甲状腺炎(HT)合并甲状腺乳头状癌(PTC)的发病率呈逐年上升的趋势,但两种疾病之间的关系一直存在较大争议。笔者就近年来有关HT合并PTC的流行病学及发病机制、标志性抗体、分子特征、临床病理学特征、影像学诊断和治疗等方面的研究进展进行综述。The incidence of Hashimoto thyroiditis(HT)combined with papillary thyroid cancer(PTC)is increasing year by year,but the relationship between them remains controversial.This paper reviews the research progress in the epidemiology and pathogenesis,marker antibody,molecular characteristics,clinical pathological features,imaging diagnosis and treatment of HT combined with PTC.

关 键 词：桥本病 甲状腺癌 乳头状 临床方案 

分 类 号：R736.1[医药卫生—肿瘤] R581.4[医药卫生—临床医学]